[ad_1]
The covid-19 vaccine developed in China could be ready to be used massively from November, An official said before the official television of the Asian giant, while the global race to reach the final round of clinical trials intensifies.
Chinese researchers have been very optimistic about their progress, and companies Sinovac Biotech and Sinopharm They even exhibited their vaccine “candidates” this month at a trade fair in Beijing.
Representatives of the firms told AFP that they expect their vaccines to be approved after the phase 3 trials, towards the end of the year.
On Monday night, the top biosecurity expert at the Chinese Center for Disease Control told the official CCTV network that a vaccine would be available to the general public “around November or December.”
Wu Guizhen did not clarify which vaccine he was referring to specifically, but yes, “according to the clinical results of phase 3, his current progress is very fast.”
The official added that he had been vaccinated himself in April and that he has been feeling well for the past few months, without specifying what vaccine he had experienced.
Actually, there are nine candidate vaccines that are being tested in humans in advanced stages, although recently some have encountered obstacles: the pharmaceutical giant AstraZeneca and the University of Oxford They circumstantially stopped clinical trials last week after a volunteer developed an unexplained side effect.
Some of the Chinese vaccine candidates have been offered to essential workers as part of an emergency use program.
A spokesperson for the Sinovac company told AFP this month that “Tens of thousands” of people had already been voluntarily vaccinated, including 90% of its employees and family members, between 2,000 and 3,000 people.
In June, the Chinese military approved a vaccine for use by its troops, which was developed by its research unit and a company dedicated to biotechnology.
[ad_2]
